From Discovery to Clinical Trials: How NCRIS Is Accelerating a Breakthrough in Ovarian Cancer Detection
21 July 2026 This breakthrough work is bringing lifesaving early‑detection tools closer to reality  Professor John Hooper and his team at Mater Research Institute and The University of Queensland are bringing new hope to women with ovarian cancer through the development of innovative imaging agents designed to detect the disease earlier, when treatment is […]
How NCRIS infrastructure helped UQ’s vaccine platform – a billion-dollar success
16 December 2025 A landmark deal has placed Australian vaccine innovation on the world stage, with leading healthcare company Sanofi completing the acquisition of Vicebio Molecular Clamp inventors Prof Keith Chappell, Prof Daniel Watterson and Em Prof Paul Young (Photo credit: The University of Queensland ) Vicebio was formed in 2019 to advance The University […]
National Biologics Facility
The National Biologics Facility (NBF) enables Australian researchers to identify and translate their biomedical research discoveries, bridging the gap between early-stage development, testing and clinical supply for next-gen therapeutic candidates. NBF is a Contract Research Organisation that for over 15 years has offered Australian researchers custom manufacturing solutions under phase-appropriate quality systems. Read more about […]